Evidence map›Paper›PMID 41263821›Full record

ArticleMicrobial genomics2025

Identification and response to a putatively hypervirulent, carbapenem-resistant

Mark I Garvey, Robert A Moran, Ana D Sanches Ferreira, Jean Harker, Sarah Wilkes, Elisabeth Holden, Alan McNally

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mark I GarveyInstitute of Microbiology and Infection, College of Medicine and Health, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Robert A MoranInstitute of Microbiology and Infection, College of Medicine and Health, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Ana D Sanches FerreiraInstitute of Microbiology and Infection, College of Medicine and Health, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
Jean HarkerUniversity Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, UK.
Sarah WilkesUniversity Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, UK.
Elisabeth HoldenUniversity Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, UK.
Alan McNallyInstitute of Microbiology and Infection, College of Medicine and Health, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Here, we describe a putatively hypervirulent, carbapenem-resistant

Indexed as

Carbapenem-Resistant EnterobacteriaceaeCross InfectionDisease OutbreaksKlebsiella InfectionsKlebsiella pneumoniaeAgedAged, 80 and overAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemsFemaleHospitalsHumansMaleMiddle AgedAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemshypervirulent, carbapenem-resistant Klebsiella pneumoniae (hv-CRKP)infection prevention and control (IPC)nanopore sequencing

Identifiers

PMID41263821
PMCPMC13293339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.